Anti‐MDA5 antibody‐positive DM has a rapid onset, more severe disease and worse prognosis, and ILD is the leading cause of death in anti‐MDA5 antibody‐positive DM patients.6, 7. This evidence concerns the gene IFIH1 and dermatomyositis.